Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
17
Drug Approvals
Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)
- Approval Date
- Sep 30, 2020
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge
- Conditions
- Surgery
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Haemonetics Corporation
- Target Recruit Count
- 338
- Registration Number
- NCT06352125
- Locations
- 🇺🇸
University of California - San Francisco, San Francisco, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
🇺🇸Ochsner Clinic, New Orleans, Louisiana, United States
Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
- Conditions
- Healthy
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Haemonetics Corporation
- Target Recruit Count
- 181
- Registration Number
- NCT06261580
- Locations
- 🇺🇸
Machaon Diagnostics, Oakland, California, United States
🇺🇸Cardiovascular Research Institute - Loyola University Chicago Health Sciences, Maywood, Illinois, United States
🇺🇸Louisiana Coagulation / Machaon Division, New Orleans, Louisiana, United States
IMPACT (Improving Plasma Collection) Clinical Trial
- Conditions
- Apheresis Related Hypotension
- First Posted Date
- 2020-03-25
- Last Posted Date
- 2021-04-09
- Lead Sponsor
- Haemonetics Corporation
- Target Recruit Count
- 3443
- Registration Number
- NCT04320823
- Locations
- 🇺🇸
Octapharma Plasma, Spokane, Washington, United States
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
- Conditions
- DOAC Eligible Subjects
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2020-02-11
- Lead Sponsor
- Haemonetics Corporation
- Target Recruit Count
- 385
- Registration Number
- NCT02798328
- Locations
- 🇺🇸
Memorial Hospital South Bend, South Bend, Indiana, United States
🇺🇸Essentia Institute of Rural Health, Duluth, Minnesota, United States
🇺🇸Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
- Conditions
- Transmission, Blood, Recipient/Donor
- First Posted Date
- 2015-06-19
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Haemonetics Corporation
- Target Recruit Count
- 62
- Registration Number
- NCT02476851
- Locations
- 🇺🇸
Haemonetics, Braintree, Massachusetts, United States
🇺🇸Hoxworth Blood Center, Cincinnati, Ohio, United States
🇺🇸American Red Cross Mid-Atlantic Region Blood Services, Norfolk, Virginia, United States
- Prev
- 1
- 2
- 3
- Next
News
Vivasure Medical Secures CE Mark for First Fully Absorbable Large-Bore Vascular Closure System
Vivasure Medical has received European CE mark approval for PerQseal Elite, the first fully absorbable, sutureless closure system designed specifically for large-bore cardiovascular procedures.